William Blair & Company’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-26,500
| Closed | -$166K | – | 1807 |
|
|
2018
Q3 | $166K | Hold |
26,500
| – | – | ﹤0.01% | 1317 |
|
|
2018
Q2 | $213K | Hold |
26,500
| – | – | ﹤0.01% | 1246 |
|
|
2018
Q1 | $198K | Hold |
26,500
| – | – | ﹤0.01% | 1206 |
|
|
2017
Q4 | $158K | Hold |
26,500
| – | – | ﹤0.01% | 1285 |
|
|
2017
Q3 | $195K | Hold |
26,500
| – | – | ﹤0.01% | 1252 |
|
|
2017
Q2 | $180K | Buy |
26,500
+2,500
| +10% | +$17K | ﹤0.01% | 1327 |
|
|
2017
Q1 | $270K | Hold |
24,000
| – | – | ﹤0.01% | 1108 |
|
|
2016
Q4 | $207K | Hold |
24,000
| – | – | ﹤0.01% | 1136 |
|
|
2016
Q3 | $152K | Buy |
+24,000
| New | +$152K | ﹤0.01% | 1180 |
|
|
2016
Q2 | – | Sell |
-24,000
| Closed | -$104K | – | 1287 |
|
|
2016
Q1 | $104K | Hold |
24,000
| – | – | ﹤0.01% | 1120 |
|
|
2015
Q4 | $147K | Hold |
24,000
| – | – | ﹤0.01% | 1114 |
|
|
2015
Q3 | $137K | Hold |
24,000
| – | – | ﹤0.01% | 1319 |
|
|
2015
Q2 | $179K | Hold |
24,000
| – | – | ﹤0.01% | 2070 |
|
|
2015
Q1 | $143K | Buy |
24,000
+12,000
| +100% | +$71.5K | ﹤0.01% | 2037 |
|
|
2014
Q4 | $90K | Hold |
12,000
| – | – | ﹤0.01% | 2022 |
|
|
2014
Q3 | $62K | Buy |
+12,000
| New | +$62K | ﹤0.01% | 2035 |
|